En savoir plus
Advances in Cancer Research, Volume 139, provides invaluable information on the exciting and fast-moving field of cancer research. Original reviews are presented on a variety of topics relating to the rapidly developing intersection between nanotechnology and cancer research, with unique sections in the new release focusing on Exosomes as a theranostic for lung cancer, Nanotechnology and cancer immunotherapy, Ultrasound imaging agents and delivery systems, Dendronized systems for the delivery of chemotherapeutics, Thermosensitive liposomes for image-guided drug delivery, Supramolecular Chemistry in Tumor Analysis and Drug Delivery, Gold nanoparticles for delivery of cancer therapeutics, and Single cell barcode microchip for cancer research and therapy.
Table des matières
1. Exosomes as Theranostics for Lung Cancer
Akhil Srivastava, Narsireddy Amreddy, Mohammad Razaq, Rheal Towner, Yan Daniel Zhao, Rebaz A. Ahmed, Anupama Munshi and Rajagopal Ramesh
2. Nanotechnology Approaches to Improving Cancer Immunotherapy
C. Tilden Hagan IV, Yusra B. Medik and Andrew Z. Wang
3. Ultrasound Contrast Agents and Delivery Systems?in Cancer Detection and Therapy
Al de Leon, Reshani Perera, Pinunta Nittayacharn, Michaela Cooley, Olive Jung and Agata A. Exner
4. Dendronized Systems for the Delivery of Chemotherapeutics
Lance Dockery and Marie-Christine Daniel
5. Thermosensitive Liposomes for Image-Guided Drug Delivery
Dieter Haemmerich and Anjan Motamarry
6. Supramolecular Analytical Chemistry in Cancer Research
Shiqun Shao and Min Xue
7. Gold Nanoparticles for the Delivery of Cancer Therapeutics
Dean M. Connor and Ann-Marie Broome
8. Single-Cell Proteomics for Cancer Immunotherapy
Linmei Li, Shiqiang Yan, Bingcheng Lin, Qihui Shi and Yao Lu
A propos de l'auteur
Ann-Marie Broome directs the Broome Translational Medicine & Nanotherapeutic Lab which integrates molecular biology, molecular chemistry, and molecular physics to bioengineer molecular imaging agents and bio-mimetic drug delivery vehicles.
Their research team combines expertise in areas of nano-material design, cell engineering, biomarker imaging, immunology, surgery, and oncology in order to develop multi-functional nanoparticles.
The overarching premise of this research is that it is possible to create multifunctional nano-therapeutics and post therapy monitoring tools with an emphasis on the development of a reliable nanotechnology-based solution for those organs where disease is characterized by low survival rates.
